Mindfully Curated
An international study of the impacts of 26 landfalling tropical cyclones reveals trade-offs between ecosystem resistance and resilience. The findings can help guide managers as they plan for climate change and its impacts to coastal ecosystems and eco…
Bioengineers have shown they can eradicate advanced-stage ovarian and colorectal cancer in mice in as little as six days with a treatment that could be ready for human clinical trials later this year.
Researchers have discovered that power-producing organelles in the eye’s photoreceptor cells, called mitochondria, function as microlenses that help channel light to these cells’ outer segments where it’s converted into nerve signals. The discovery in …
New research has found that people who spent more time in green spaces reported less anxiety and depression during the first year of the pandemic. Merely having abundant green space nearby, as measured by satellite images, was associated with lower dep…
Renewable energy that feeds into the main power grid could destabilize the system and potentially cause power failures according to a new study.
The sports retailer reported earnings and investors seemed to like what the company had to say.
The company posted strong revenue growth in the fourth quarter, but expenses grew even faster.
Investors were looking for some good news from this beaten-down stock and they got it.
The next year may feature gray skies, but there’s more to a stock’s future than just one year.
BHG earnings call for the period ending December 31, 2021.
ATRO earnings call for the period ending December 31, 2021.
This casino supplier surprised the market with plans to unlock more value for shareholders.
The big-data software stock is trading at a huge discount compared to last year’s high.
Stock markets got a bit of relief on Wednesday.
HPE beat analyst earnings estimates with a stick.
The biotech’s better-than-expected Q4 financial results are fueling a rally in its stock.
The fuel cell specialist told investors what they wanted to hear.
An optimistic analyst upgrade is powering the biotech’s shares higher today.
The pharma titan’s shares are being buoyed by two important catalysts.
You can probably blame President Joe Biden for this one.